Switch to Josette-Renée Landry's research page...

In Press

1. Wilhelm BT, Landry JR, Takei F, Mager DL. Transcriptional control of the murine CD94 gene: differential usage of dual promoters by lymphoid cell types J Immunol (In Press).
    Request Paper

2. van de Lagemaat L, Landry JR, Mager DL, Medstrand P. Transposable elements promote regulatory variation and diversification of genes with specialized functions in mammals Trends Genet (In Press).
    Request Paper

2003

3. Landry JR, Mager DL. Functional analysis of the endogenous retroviral promoter of the human endothelin B receptor gene. J Virol 77(13):7459-66. (2003).
    [View Abstract - PubMed 12805445]  Request Paper

2002

4. Landry JR, Mager DL. Widely spaced alternative promoters, conserved between human and rodent, control expression of the Opitz syndrome gene MID1. Genomics 80(5):499-508. (2002).
    [View Abstract - PubMed 12408967]  Request Paper

5. Landry JR, Rouhi A, Medstrand P, Mager DL. The Opitz syndrome gene MID1 is transcribed from a human endogenous retroviral promoter. Mol Biol Evol 19(11):1934-42. (2002).
    [View Abstract - PubMed 12411602]  Request Paper

2001

6. Landry JR, Medstrand P, Mager DL. Repetitive elements in the 5' untranslated region of a human zinc-finger gene modulate transcription and translation efficiency. Genomics 76(1-3):110-6. (2001).
    [View Abstract - PubMed 11549323]  Request Paper

7. Medstrand P, Landry JR, Mager DL. Long terminal repeats are used as alternative promoters for the endothelin B receptor and apolipoprotein C-I genes in humans. J Biol Chem 276(3):1896-903. (2001).
    [View Abstract - PubMed 11054415]  Request Paper